Gelmer Leibbrandt

Gelmer Leibbrandt has extensive experience in the pharmaceutical and biopharma industries, holding various leadership roles in companies such as Teva Pharmaceuticals Europe BV, Nobilon (part of Schering-Plough), and Sanquin. With a background in economics and an e-MBA from New York Institute of Technology, Gelmer has demonstrated strong strategic and operational capabilities in roles such as CEO, Director of Strategy & Operations, and General Manager. Their accomplishments include launching the first BioSimilar to Neulasta on the EU market and leading culture change programs within organizations. Gelmer's expertise in marketing, sales, and brand management has been instrumental in the growth and success of the companies Gelmer has been a part of.